GlassScriptPhysician profile
Kurt W Erickson
NPI 1033173125
$6,380.73
in general payments reported to CMS, 2019-2025
32 companies · $1,273 in 2025
The $1,273 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $554 · 2021: $1,031 · 2022: $1,291 · 2023: $515 · 2024: $1,242 · 2025: $1,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,030.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,291.97 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $806.61 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $545.32 | 2019-2025 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $431.15 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Amgen INC. | $384.61 | 2019-2025 | Repatha |
| Pfizer INC. | $353.38 | 2019-2025 | |
| Esperion Therapeutics, INC. | $295.09 | 2020-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $250.81 | 2019-2024 | Andexxa, Brilinta, Lokelma |
| Novo Nordisk INC | $242.55 | 2024-2025 | Wegovy, Ozempic |
| Merck Sharp & Dohme LLC | $222.95 | 2022-2025 | Verquvo, Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.74 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $180.61 | 2019-2023 | Lifevest |
| Shockwave Medical, INC | $176.11 | 2022 | |
| Chiesi USA, INC. | $167.67 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $142.45 | 2024-2025 | Onpattro, Amvuttra |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $125.67 | 2025 | Assure Wcd |
| Medtronic Vascular, INC. | $116.45 | 2020 | |
| Daiichi Sankyo INC. | $85.65 | 2024 | Injectafer |
| Amarin Pharma, INC. | $58.08 | 2020-2022 | |
| Scpharmaceuticals INC. | $55.18 | 2024-2025 | |
| Medtronic, INC. | $42.87 | 2024-2025 | Aurora Ev-Icd Mri Surescan, Micra |
| Kiniksa Pharmaceuticals, LTD. | $40.24 | 2022-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $27.52 | 2024 | Arcalyst |
| Astellas Pharma US INC | $24.64 | 2020 | |
| Cvrx, INC. | $20.14 | 2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $16.60 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $16.44 | 2023 | Inpefa |
| Boston Scientific Corporation | $15.90 | 2021 | |
| Lundbeck LLC | $15.53 | 2020 | |
| W. L. Gore & Associates, INC. | $15.19 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.90 | 2020 | |
| Infobionic, INC | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.